Report dose-to-medium in clinical trials; a consensus from the Global Harmonisation Group

被引：0

作者：

Kry, S. ^{[1
]}

Lye, J. ^{[2
,3
]}

Clark, C. ^{[4
,5
,6
,7
]}

Andratschke, N. ^{[8
,9
]}

Dimitriadis, A. ^{[10
]}

Followill, D. ^{[1
]}

Howell, R. ^{[11
]}

Hussein, M. ^{[12
]}

Ishikawa, M. ^{[13
]}

Kito, S. ^{[14
]}

Kron, T. ^{[15
]}

Lee, J. ^{[16
]}

Michalski, J. ^{[17
]}

Monti, A. ^{[18
]}

Reynaert, N. ^{[19
]}

Taylor, P. ^{[1
]}

Venables, K. ^{[20
]}

Xiao, Y. ^{[21
]}

Lehmann, J. ^{[22
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Imaging & Radiat Oncol Core, Radiat Phys, Houston, TX 77030 USA

[2] Australian Radiat Protect & Nucl Safety Agcy, Australian Clin Dosimetry Serv, Melbourne, Vic, Australia

[3] Olivia Newton John Canc Res & Wellness Ctr, Radiat Phys, Melbourne, Vic, Australia

[4] NIHR Radiotherapy Trials Qual Assurance Grp, London, England

[5] Univ Coll London Hosp, London, England

[6] UCL, London, England

[7] Natl Phys Lab, Radiat Phys, London, England

[8] Univ Zurich, European Org Res & Treatment Canc Radiotherapy Qu, Radiat Oncol, Zurich, Switzerland

[9] Univ Zurich, Univ Hosp Zurich, Radiat Oncol, Zurich, Switzerland

[10] IAEA, Dosimetry & Med Radiat Phys Sect, Vienna, Austria

[11] Univ Texas MD Anderson Canc Ctr, Radiat Dosimetry Serv, Radiat Phys, Houston, TX 77030 USA

[12] Natl Phys Lab, Phys, Teddington, Middx, England

[13] Hokkaido Univ, Fac Hlth Sci, Japan Clin Oncol Grp, Sapporo, Hokkaido, Japan

[14] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Japan Clin Oncol Grp, Radiat Oncol, Tokyo, Japan

[15] Peter MacCallum Canc Ctr, Trans Tasman Radiat Oncol Grp TROG, Radiat Oncol, Melbourne, Vic, Australia

[16] Mt Vernon Canc Ctr, NIHR Radiotherapy Trials Qual Assurance Grp, Radiat Oncol, Northwood, Middx, England

[17] Washington Univ, Sch Med, Imaging & Radiat Oncol Core, Radiat Oncol, St Louis, MO USA

[18] ASST GOM Niguarda Hosp, European Org Res & Treatment Canc EORTC, Med Phys, Milan, Italy

[19] Univ Libre Bruxelles, Jules Bordet Inst, European Org Res & Treatment Canc, Med Phys, Brussels, Belgium

[20] Mt Vernon Canc Ctr, NIHR Radiotherapy Trials Qual Assurance Grp, Radiat oncol, Northwood, Middx, England

[21] Univ Penn, Imaging & Radiat Oncol Core, Radiat Oncol, Philadelphia, PA 19104 USA

[22] Calvary Mater Newcastle, Trans Tasman Radiat Oncol Grp TROG, Radiat Oncol, Newcastle, NSW, Australia

来源：

RADIOTHERAPY AND ONCOLOGY | 2021年 / 161卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PD-0899

引用

页码：S738 / S739

页数：2

共 50 条

[1] A Consensus Report from the Global Harmonisation Group On Clinical Trials: Report Dose-To-Medium
Kry, S.
Lye, J.
Clark, C.
Andratschke, N.
Dimitriadis, A.
Followill, D.
Howell, R.
Hussein, M.
Ishikawa, M.
Kito, S.
Kron, T.
Lee, J.
Michalski, J.
Monti, A.
Reynaert, N.
Taylor, P.
Venables, K.
Xiao, Y.
Lehmann, J.
[J]. MEDICAL PHYSICS, 2021, 48 (06)
[2] Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistency
Kry, Stephen F.
Lye, Jessica
Clark, Catharine H.
Andratschke, Nicolaus
Dimitriadis, Alexis
Followill, David
Howell, Rebecca
Hussein, Mohammad
Ishikawa, Masayori
Kito, Satoshi
Kron, Tomas
Lee, Jonny
Michalski, Jeff
Monti, Angelo Filippo
Reynaert, Nick
Taylor, Paige
Venables, Karen
Xiao, Ying
Lehmann, Joerg
[J]. RADIOTHERAPY AND ONCOLOGY, 2021, 159 : 106 - 111
[3] Radiation therapy quality assurance in clinical trials - Global harmonisation group
Melidis, Christos
Bosch, Walter R.
Izewska, Joanna
Fidarova, Elena
Zubizarreta, Eduardo
Ishikura, Satoshi
Followill, David
Galvin, James
Xiao, Ying
Ebert, Martin A.
Kron, Tomas
Clark, Catharine H.
Miles, Elizabeth A.
Aird, Edwin G. A.
Weber, Damien C.
Ulin, Kenneth
Verellen, Dirk
Hurkmans, Coen W.
[J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 (03) : 327 - 329
[4] What Dose Specification Should be used for NRG Radiation Therapy Trials, Dose-to-Medium or Dose-to-Water?
Cabanas, M.
Yan, C.
Lalonde, R. J.
Heron, D. E.
Huq, S.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E531 - E532
[5] Consistency of OAR delineation for clinical trials: A Global Harmonization Group Consensus
Mir, R.
Kelly, S.
Xiao, Y.
Moore, A.
Clark, C.
Clementel, E.
Corning, C.
Ebert, M.
Hoskin, P.
Hurkmans, C.
Ishikura, S.
Kristensen, I.
Kry, S.
Lehmann, J.
Michalski, J.
Monti, A.
Nakamura, M.
Thompson, K.
Yang, H.
Zubizarreta, E.
Andratschke, N.
Miles, E.
[J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S682 - S683
[6] Which Dose Specification Should Be Used for NRG Radiation Therapy Trials: Dose-to-Medium or Dose-to-Water?
Cabanas, Maria Lavin
Yan, Chenyu
Lalonde, Ronald J.
Heron, Dwight E.
Huq, M. Saiful
[J]. PRACTICAL RADIATION ONCOLOGY, 2020, 10 (02) : E103 - E110
[7] From AAA to Acuros XB-clinical implications of selecting either Acuros XB dose-to-water or dose-to-medium
Zifodya, Jackson M.
Challens, Cameron H. C.
Hsieh, Wen-Long
[J]. AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE, 2016, 39 (02) : 431 - 439
[8] From AAA to Acuros XB-clinical implications of selecting either Acuros XB dose-to-water or dose-to-medium
Jackson M. Zifodya
Cameron H. C. Challens
Wen-Long Hsieh
[J]. Australasian Physical & Engineering Sciences in Medicine, 2016, 39 : 431 - 439
[9] Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines
Mir, Romaana
Kelly, Sarah M.
Xiao, Ying
Moore, Alisha
Clark, Catharine H.
Clementel, Enrico
Corning, Coreen
Ebert, Martin
Hoskin, Peter
Hurkmans, Coen W.
Ishikura, Satoshi
Kristensen, Ingrid
Kry, Stephen F.
Lehmann, Joerg
Michalski, Jeff M.
Monti, Angelo F.
Nakamura, Mitsuhiro
Thompson, Kenton
Yang, Huiqi
Zubizarreta, Eduardo
Andratschke, Nicolaus
Miles, Elizabeth
[J]. RADIOTHERAPY AND ONCOLOGY, 2020, 150 : 30 - 39
[10] Clinical trials for children with cancer in Europe - Still a long way from harmonisation: A report from SIOP Europe
Pritchard-Jones, K.
[J]. EUROPEAN JOURNAL OF CANCER, 2008, 44 (15) : 2106 - 2111

← 1 2 3 4 5 →